TSH-secreting adenoma improved with cabergoline

Annales d'Endocrinologie

Volumn 69, Issue 3, 2008, Pages 244-248

  Mouton, F ^a   Faivre Defrance, F ^a   Cortet Rudelli, C ^a   Assaker, R ^a   Soto Ares, G ^a   Defoort Dhellemmes, S ^a   Blond, S ^a   Wemeau, J L ^a   Vantyghem, M C ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cabergoline; Stereotactic radiotherapy; TSH secreting adenoma; Visual impairment

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; OCTREOTIDE; OCTREOTIDE I 123; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; THYROID HORMONE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG UPTAKE; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTHYROIDISM; INJECTION SITE REACTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTIGRAPHY; THYROID HORMONE BLOOD LEVEL; THYROTROPIN SECRETING ADENOMA; TRANSSPHENOIDAL SURGERY;

ADULT; ANTINEOPLASTIC AGENTS; BONE AND BONES; ERGOLINES; HUMANS; MALE; PITUITARY NEOPLASMS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 46549084836     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2008.02.001     Document Type: Article

References (28)

1. Prevost G., Vantyghem M.C., Hober C., et al. Thyreotropic adenoma: review of the literature a propos of 2 cases. Ann Endocrinol (Paris) 57 (1996) 194-202
2. Socin H.V., Chanson P., Delemer B., et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management of 43 patients. Eur J Endocrinol 148 (2003) 433-442
3. Gesundheit N., Petrick P.A., Nissi M., et al. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med 15 111 (1989) 827-835
4. Mc Cutcheon I.E., Weintraub B.D., and Oldfield E.H. Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg 73 (1990) 674-683
5. Losa M., Giovanelli M., Persani L., Mortini P., et al. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81 (1996) 3084-3090
6. Ness-Abramof R., Ishay A., Harel G., et al. TSH-secreting pituitary adenomas: follow-up of 11 cases and review of the literature. Pituitary (2007, Mar 9) (Epub ahead of print)
7. Wemeau J.L., Dewailly D., Leroy R., D'Herbomez M., Mazzuca M., et al. Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 66 (1988) 636-639
8. Brucker Davis F., Oldfield E.H., Skarulis, et al. Thyrotropin-secreting pituitary tumors: diagnosis criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84 (1999) 476-486
9. Sanno N., Teramoto A., and Osamura RY. long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg 93 (2000) 194-200
10. Sudhakar N., Ray A., and Vafidis J.A. Complications after trans-sphenoidal surgery: our experience and a review of the literature. Br J Neurosurg 18 (2004) 507-512
11. Polak M., Bertherat J., Li J.Y., Kujas M., et al. A human TSH-secreting adenoma: endocrine, biochemical and morphological studies. Evidence of somatostatin receptors by using quantitative autoradiography. Clinical and biological improvement by SMS 201-995 treatment. Acta Endocrinol (Copenh) 124 (1991) 479-486
12. Becker G., Kocher M., Kortmann R.D., Paulsen F., et al. Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 178 (2002) 173-186
13. Gilliot O., Khalil T., Irthum B., et al. Radiotherapy of pituitary adenomas: state of the art. Ann Endocrinol (Paris) (2007, May 18) [Epub ahead of print]
14. Minniti G., Traish D., Ashley S., Gonsalvs A., and Brada M. Fractionated stereotactic conformal radiotherapy for secreting and non secreting pituitary adenomas. Clin Endocrinol 64 (2006) 542-548
15. Girkin Ca, Comey C.H., Lunsford L.D., Goodman M.L., and Kline L.B. Radiation optic neuropathy after stereotactic radiosurgery. Ophtalmology 104 (1997) 1634-1643
16. Stafford S.L., Pollock B.E., Leavitt J.A., et al. A study on the radiation tolerance of the optic nerves and chiasm after stereotactc radiosurgery. Int J Radiat Oncol Biol Phys 55 (2003) 1177-1181
17. Beck Peccoz P., Mariotti S., Guillausseau P.J., Medri G., et al. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. J Clin Endocrinol Metab 68 (1989) 208-214
18. Chanson P., Weintraub B.D., and Harris A.G. Octreotide therapy for thyroid-stimulating pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119 (1993) 236-240
19. Caron P., Arlot S., Bauters C., Chanson P., et al. Efficacy of the long-acting octreotide formulation (octreotide-lar) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 86 (2001) 2849-2853
20. Shimatsu A., Murabe H., Kamoi K., Suzuki Y., et al. Treatment of thyrotropin-secreting pituitary adenomas with octreotide. Endocr J 46 (1999) 113-123
21. Warnet A., Timsit J., Chanson P., Guillausseau P.J., et al. The effect of somatostatin analogue on chiasmal dysfunction from pituitary macroadenomas. J Neurosurg 71 5 Pt 1 (1989) 687-690
22. Boulis N.M., Noordmans A.J., Barkan A., Hassing J., et al. Somatotrophinoma infarction during octréotide therapy leading to bilateral cavernous syndrome. Pituitary 3 3 (2000) 185-188
23. Chanson P., Timsit J., and Harris A.G. Octeotide, analog of somatostatin. Pharmalogical properties and therapeutic application in pituitary endocrine tumors. Press med 22 (1993) 2009-2016
24. Kuhn J.M., Arlot S., Lefebvre P., Caron C., et al. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab 85 (2000) 1487-1491
25. Yoenem A., Cakyr B., Azal O., Corakcy A., et al. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the litterature. Endocr Regul 33 (1999) 169-174
26. Camacho P., and Mazzone T. Thyrotropin-secreting pituitary adenoma responsive to bromocriptine therapy. Endocr Pract 5 (1999) 257-260
27. Mulinda J.R., Hasinski S., and Rose L.I. Successful therapy for a mixed thyrotropin- and prolactin- secreting pituitary macro-adenoma with cabergoline. Endocr Pract 5 (1999) 76-79
28. Kienitz T., Quinkler M., Strasburger C.J., and Ventz M. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. Eur J Endocrinol 157 (2007) 39-46